Clinical Trials
8 trialsNCT05722795 2025-07-09
I-CONIC
Vastra Gotaland Region
Phase NA Recruiting
NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT00323063 2023-03-29
Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT00080665 2018-04-24
Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00372476 2017-02-07
INV181
Novartis
Phase 4 Completed
NCT00193180 2016-05-27
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00087152 2014-06-09
S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00045188 2013-01-23
Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed